Psychotic Disorders - Niger | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$3.59m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.03%, resulting in a market volume of US$3.97m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$16.73 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Niger is experiencing steady growth due to a combination of customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Psychotic Disorders market in Niger are shifting towards a greater emphasis on mental health and well-being. As awareness about mental health issues increases, more people are seeking treatment for psychotic disorders. This is driving the demand for medications and therapies that can effectively manage these conditions. Additionally, there is a growing preference for holistic approaches to treatment, including alternative therapies and lifestyle changes. Customers are also increasingly looking for personalized treatment plans that take into account their individual needs and circumstances.Trends in the market are also contributing to the growth of the Psychotic Disorders market in Niger. One key trend is the increasing availability and accessibility of mental health services. The government and non-governmental organizations are investing in the expansion of mental health facilities and the training of healthcare professionals. This is making it easier for individuals to access the care they need. Another trend is the integration of mental health services into primary care settings. This approach allows for early detection and intervention, leading to better outcomes for patients.Local special circumstances in Niger are influencing the development of the Psychotic Disorders market. The country has a high prevalence of mental health disorders, including psychotic disorders. This is attributed to a combination of factors such as poverty, conflict, and limited access to healthcare. As a result, there is a pressing need for effective treatments and interventions. The government and international organizations are working to address these challenges by implementing mental health policies and programs. This has created opportunities for pharmaceutical companies and healthcare providers to expand their presence in the market.Underlying macroeconomic factors are also driving the growth of the Psychotic Disorders market in Niger. The country's economy has been growing steadily, leading to increased disposable income and improved healthcare infrastructure. This has resulted in greater affordability and accessibility of mental health services. Additionally, the government has implemented health insurance schemes that cover mental health treatments, further incentivizing individuals to seek care. These factors are creating a favorable market environment for the Psychotic Disorders market to thrive.In conclusion, the Psychotic Disorders market in Niger is experiencing growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. As the country continues to prioritize mental health and invest in healthcare infrastructure, the market is expected to expand further.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.